Idursulfase (Elaprase, Takeda Pharmaceuticals) and idursulfase beta (Hunterase, GC Biopharma Corp.)are the two currently available enzyme replacement therapies (ERT) for MPS II in Malaysia. The gene discussed is IDS; the disease is mucopolysaccharidosis type 2.